XML 24 R12.htm IDEA: XBRL DOCUMENT
v3.24.3

ACCOUNTS PAYABLE AND ACCRUED LIABILITIES | 6 Months Ended
--- | ---
Sep. 30, 2024
Accounts Payable And Accrued Liabilities |
ACCOUNTS PAYABLE AND ACCRUED LIABILITIES | NOTE 7. ACCOUNTS PAYABLE AND ACCRUED LIABILITIES At September 30, 2024 and March 31, 2024, accounts payable and accrued liabilities were comprised of the following (in thousands):
Schedule of accounts payable and accrued liabilities |  |  |  |  |  |  |  |
|  | September 30, 2024 (Unaudited) |  | March 31, 2024
Accounts payable and amounts accrued to CRO |  | $ | 49 |  |  | $ | 1,413 |
Accrued bonuses and other payroll-related expenses |  |  | 371 |  |  |  | 525 |
Accrued accounting and auditing fees |  |  | 127 |  |  |  | 189 |
Accrued legal fees |  |  | 54 |  |  |  | 194 |
Accrued other professional fees |  |  | 33 |  |  |  | 157 |
Other accounts payable |  |  | 172 |  |  |  | 136 |
Accrued clinical and R&D services |  |  | 3 |  |  |  | 179 |
Other |  |  | 36 |  |  |  | 43 |
Total accounts payable and accrued liabilities |  | $ | 845 |  |  | $ | 2,836 |
The decrease in accounts payable and accrued liabilities from $2.8 million as of March 31, 2024 to $0.8 million as of September 30, 2024 is primarily attributable to the write-off of $1.486 million in connection with the settlement with Parexel. Refer to the “iOx – Parexel Master Services Agreement” section of Note 12, “Commitments and Contingent Liabilities” for further discussion regarding this matter.

X
- References No definition available. + Details
Name: | ptgef_AccountsPayableAndAccruedLiabilitiesTextBlock
Namespace Prefix: | ptgef_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | ptgef_DisclosureAccountsPayableAndAccruedLiabilitiesAbstract
Namespace Prefix: | ptgef_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration